Diabetes increases risk of heart attack death by 50%

Diabetes increases risk of heart attack death by 50%

June 29 2016 A new study has shown the importance of managing type 2 diabetes to help reduce the...

EMA issues warning that Noxafil tablets and oral suspension not interchangeable

EMA issues warning that Noxafil tablets and oral suspension not interchangeable

June 27 2016 The tablet and oral suspension preparations of Noxafil (posaconazole) are not...

GPhC to address issues relating to workplace pressures

GPhC to address issues relating to workplace pressures

June 22 2016 The General Pharmaceutical Council is look at how pharmacy professionalism is being...

RPS supports introduction of disclosure of pharma payments register for health professionals

RPS supports introduction of disclosure of pharma payments register for health professionals

June 20 2016 The Royal Pharmaceutical Society has supported steps being taken to introduce a...

CPPE Community Pharmacy Competence Group re-launches DoC

CPPE Community Pharmacy Competence Group re-launches DoC

June 13 2016 The Declaration of Competence (DoC) framework has been revised and re-launched with...

  • Diabetes increases risk of heart attack death by 50%

    Diabetes increases risk of heart attack death by 50%

    Wednesday, 29 June 2016 11:43
  • EMA issues warning that Noxafil tablets and oral suspension not interchangeable

    EMA issues warning that Noxafil tablets and oral suspension not interchangeable

    Tuesday, 28 June 2016 13:46
  • GPhC to address issues relating to workplace pressures

    GPhC to address issues relating to workplace pressures

    Wednesday, 22 June 2016 14:19
  • RPS supports introduction of disclosure of pharma payments register for health professionals

    RPS supports introduction of disclosure of pharma payments register for health professionals

    Tuesday, 21 June 2016 11:59
  • CPPE Community Pharmacy Competence Group re-launches DoC

    CPPE Community Pharmacy Competence Group re-launches DoC

    Monday, 13 June 2016 11:30

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

CommunityPharmacyResearchApril 27 2016

Community pharmacies which undertake practice research programmes report benefits such as increased credibility as a high quality pharmacy service provider, a study has suggested. Active participation in research also can benefit patients and the public with the potential for improved quality of care and patient outcomes.

The advantages of pharmacy participation are included in an evaluation of the Royal Pharmaceutical Society’s community pharmacy Ready Research Programme. This is an accreditation programme which aims to support community pharmacies getting involved in research studies across Great Britain.

Aims of the online programme, which covers the basic requirements for undertaking primary care, are to:

  • ensure pharmacies undertaking the accreditation process meet the standards outlined in the Department of Health’s Research Governance Framework
  • increase the routine involvement of community pharmacies in funded research, with appropriate financial reward for their time;
  • encourage national research infrastructures to select community pharmacies as research sites;
  • provide adequate support for community pharmacies to undertake research and increase opportunities for research.

Since its launch in September 2013, nearly 200 pharmacies have engaged with Research Ready. Feedback from a survey of these pharmacies with 72 responses, found that all research leads were pharmacists, with 81% being RPS members, but only 1% being RPS Faculty members. “It was also evident that the majority of pharmacies were either multiple independents or independent pharmacies, which have between seven and nine staff,” said the Society.

Among the sorts of research activities undertaken by accredited pharmacies have been signposting patients to studies, raising awareness of the importance of health-related research in the NHS, and recruiting patients into studies or formally taking consent from participants and enabling them to take part in a study. Smaller proportions of pharmacies reported having been involved in managing and dispensing clinical trial medication or actively delivering a study intervention.

The evaluation of the programme concluded: “Pharmacy leads identified professional and business development as the most important factors for becoming accredited. Of those that responded, 61% were already involved in research prior to becoming accredited and aware of the benefit research yields to improve patient care.

“The advantages of accreditation for the business included increased credibility as a high quality provider, service development and innovation, and building stronger links with industry and academia. Research leads’ perception as the greatest advantages of the accreditation for patients and the public included, increased accessibility to research and improved quality of care and patient outcomes.”

Dr Rachel Joynes, Head of Research and Evaluation at the RPS, added: “We are keen to demystify research for community pharmacy and break down perceived barriers to research engagement. Research Ready enables pharmacy to engage in research on their own terms in a way that is meaningful and practical for both business and professional development needs.”

Links:

RPS announcement

RPS Community Pharmacy Ready Research Programme

Practice News

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as at GP practices, the New NHS Alliance has proposed.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...